ced1e44f5df4f4a4a4a6e711739f5e11  pmc_32052473.pdf
19a3ed4d3969677279e3f0713fb54806533f9ec2  pmc_32052473.pdf
fc79069c635df8cf7432394559eb31b77504d802a744f335ca874cd0faddf064  pmc_32052473.pdf

Title:          Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
Creator:        Arbortext Advanced Print Publisher 9.1.520/W Unicode
Producer:       Acrobat Distiller 11.0 (Windows)
CreationDate:   Fri Apr 10 13:39:30 2020 CEST
ModDate:        Fri Apr 10 13:39:30 2020 CEST
Tagged:         no
UserProperties: no
Suspects:       no
Form:           none
JavaScript:     no
Pages:          11
Encrypted:      no
Page size:      595.276 x 782.362 pts
Page rot:       0
File size:      1479859 bytes
Optimized:      yes
PDF version:    1.7

name                                 type              encoding         emb sub uni object ID
------------------------------------ ----------------- ---------------- --- --- --- ---------
ICJBLD+AdvTTfac587ca.B               Type 1C           WinAnsi          yes yes no     206  0
ICJBLE+AdvTT6071803a.B               Type 1C           WinAnsi          yes yes no     207  0
ICJBOE+AdvTTa9c1b374                 Type 1C           WinAnsi          yes yes no     208  0
ICJBOF+AdvTT5843c571+02              Type 1C           Custom           yes yes yes    209  0
ICJDHN+AdvTTeb5f0e55.I               Type 1C           WinAnsi          yes yes no     210  0
ICJDHO+AdvTTa9c1b374+20              Type 1C           WinAnsi          yes yes no     211  0
ICJDJO+AdvOT8608a8d1+22              Type 1C           Custom           yes yes yes     82  0
ICJDJP+AdvOT8608a8d1+03              Type 1C           Custom           yes yes yes     83  0
ICJDKA+AdvTTa9c1b374+22              Type 1C           Custom           yes yes yes     84  0
ICJECN+AdvOT8608a8d1                 Type 1C           WinAnsi          yes yes no      11  0

Jhove (Rel. 1.22.1, 2019-04-17)
 Date: 2020-11-18 06:59:34 CET
 RepresentationInformation: pmc_32052473.pdf
  ReportingModule: PDF-hul, Rel. 1.12.1 (2019-04-17)
  LastModified: 2020-08-03 03:36:47 CEST
  Size: 1479859
  Format: PDF
  Version: 1.7
  Status: Well-Formed and valid
  SignatureMatches:
   PDF-hul
  MIMEtype: application/pdf
  Profile: Linearized PDF
  PDFMetadata: 
   Objects: 226
   FreeObjects: 1
   IncrementalUpdates: 1
   DocumentCatalog: 
    PageLayout: SinglePage
    PageMode: UseNone
    Outlines: 
     Item: 
      Title: Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
      Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@ed9d034
      Children: 
       Item: 
        Title: 1  INTRODUCTION
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6121c9d6
       Item: 
        Title: 2  METHODS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@87f383f
        Children: 
         Item: 
          Title: 2.1  Study design and treatments
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4eb7f003
         Item: 
          Title: 2.2  Patients
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@eafc191
         Item: 
          Title: 2.3  Endpoints and assessments
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612fc6eb
         Item: 
          Title: 2.4  Statistical analyses
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1060b431
       Item: 
        Title: 3  RESULTS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@612679d6
        Children: 
         Item: 
          Title: 3.1  Patient population and disposition
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@11758f2a
         Item: 
          Title: 3.2  Safety
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@e720b71
         Item: 
          Title: 3.3  Pharmacokinetics
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@1b26f7b2
         Item: 
          Title: 3.4  Immunogenicity
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@491cc5c9
         Item: 
          Title: 3.5  Efficacy
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@74ad1f1f
         Item: 
          Title: 3.6  Pharmacodynamics
          Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@6a1aab78
       Item: 
        Title: 4  DISCUSSION
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@462d5aee
       Item: 
        Title: ACKNOWLEDGMENTS
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@69b0fd6f
       Item: 
        Title:   CONFLICT OF INTEREST
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@757942a1
       Item: 
        Title: REFERENCES
        Destination: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject@4a87761d
   Info: 
    Title: Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma
    Creator: Arbortext Advanced Print Publisher 9.1.520/W Unicode
    Producer: Acrobat Distiller 11.0 (Windows)
    CreationDate: Fri Apr 10 14:09:30 CEST 2020
    ModDate: Fri Apr 10 14:09:30 CEST 2020
   ID: 0xf28a526e6abc87ba35cce1895ac38933, 0x7e6e5d0774a95647f20f1e6ce8ac2e0e
   Filters: 
    FilterPipeline: FlateDecode
   Fonts: 
    Type1: 
     Font: 
      BaseFont: ICJBOE+AdvTTa9c1b374
      FontSubset: true
      FirstChar: 37
      LastChar: 242
      FontDescriptor: 
       FontName: ICJBOE+AdvTTa9c1b374
       Flags: Nonsymbolic
       FontBBox: -41, -177, 1010, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ICJBOF+AdvTT5843c571+02
      FontSubset: true
      FirstChar: 1
      LastChar: 1
      FontDescriptor: 
       FontName: ICJBOF+AdvTT5843c571+02
       Flags: Symbolic
       FontBBox: -93, -218, 843, 885
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ICJDHN+AdvTTeb5f0e55.I
      FontSubset: true
      FirstChar: 45
      LastChar: 122
      FontDescriptor: 
       FontName: ICJDHN+AdvTTeb5f0e55.I
       Flags: Nonsymbolic
       FontBBox: -83, -177, 989, 927
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ICJDJO+AdvOT8608a8d1+22
      FontSubset: true
      FirstChar: 1
      LastChar: 138
      FontDescriptor: 
       FontName: ICJDJO+AdvOT8608a8d1+22
       Flags: Symbolic
       FontBBox: 0, -322, 1218, 968
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ICJDHO+AdvTTa9c1b374+20
      FontSubset: true
      FirstChar: 150
      LastChar: 150
      FontDescriptor: 
       FontName: ICJDHO+AdvTTa9c1b374+20
       Flags: Nonsymbolic
       FontBBox: -239, -218, 1166, 937
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ICJDJP+AdvOT8608a8d1+03
      FontSubset: true
      FirstChar: 1
      LastChar: 4
      FontDescriptor: 
       FontName: ICJDJP+AdvOT8608a8d1+03
       Flags: Symbolic
       FontBBox: -479, -364, 854, 927
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ICJDKA+AdvTTa9c1b374+22
      FontSubset: true
      FirstChar: 1
      LastChar: 3
      FontDescriptor: 
       FontName: ICJDKA+AdvTTa9c1b374+22
       Flags: Symbolic
       FontBBox: 0, -166, 677, 854
       FontFile3: true
      EncodingDictionary: 
       Differences: true
      ToUnicode: true
     Font: 
      BaseFont: ICJECN+AdvOT8608a8d1
      FontSubset: true
      FirstChar: 215
      LastChar: 215
      FontDescriptor: 
       FontName: ICJECN+AdvOT8608a8d1
       Flags: Nonsymbolic
       FontBBox: -62, -208, 927, 958
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ICJBLD+AdvTTfac587ca.B
      FontSubset: true
      FirstChar: 49
      LastChar: 84
      FontDescriptor: 
       FontName: ICJBLD+AdvTTfac587ca.B
       Flags: Nonsymbolic
       FontBBox: -72, -177, 1062, 958
       FontFile3: true
      Encoding: WinAnsiEncoding
     Font: 
      BaseFont: ICJBLE+AdvTT6071803a.B
      FontSubset: true
      FirstChar: 40
      LastChar: 124
      FontDescriptor: 
       FontName: ICJBLE+AdvTT6071803a.B
       Flags: Nonsymbolic
       FontBBox: -52, -177, 1041, 947
       FontFile3: true
      Encoding: WinAnsiEncoding
   XMP: <x:xmpmeta xmlns:x="adobe:ns:meta/" x:xmptk="Adobe XMP Core 5.4-c005 78.147326, 2012/08/23-13:03:03 ">
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<rdf:Description rdf:about=""
xmlns:xmp="http://ns.adobe.com/xap/1.0/"
xmlns:pdf="http://ns.adobe.com/pdf/1.3/"
xmlns:pdfx="http://ns.adobe.com/pdfx/1.3/"
xmlns:jav="http://www.niso.org/schemas/jav/1.0/" 
xmlns:prism="http://prismstandard.org/namespaces/basic/3.0/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:xmpMM="http://ns.adobe.com/xap/1.0/mm/">
<jav:journal_article_version>VoR</jav:journal_article_version>
<prism:doi>10.1002/ajh.25757</prism:doi>
<pdfx:WPS-ARTICLEDOI>10.1002/ajh.25757</pdfx:WPS-ARTICLEDOI>
<pdfx:WPS-JOURNALDOI>10.1002/(ISSN)1096-8652</pdfx:WPS-JOURNALDOI>
<pdfx:WPS-PROCLEVEL>3</pdfx:WPS-PROCLEVEL> 
<dc:title>
<rdf:Alt>
<rdf:li xml:lang="x-default">Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma</rdf:li>
</rdf:Alt>
</dc:title>
</rdf:Description>
</rdf:RDF>
</x:xmpmeta>
   Pages: 
    Page: 
     Label: 1
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 489, 579, 497, 587
      Annotation: 
       Subtype: Link
       Rect: 66, 200, 123, 207
      Annotation: 
       Subtype: Link
       Rect: 206, 65, 299, 72
      Annotation: 
       Subtype: Link
       Rect: 77, 25, 181, 32
     Thumb: true
    Page: 
     Label: 2
     Thumb: true
    Page: 
     Label: 3
     Thumb: true
    Page: 
     Label: 4
     Thumb: true
    Page: 
     Label: 5
     Thumb: true
    Page: 
     Label: 6
     Thumb: true
    Page: 
     Label: 7
     Thumb: true
    Page: 
     Label: 8
     Thumb: true
    Page: 
     Label: 9
     Thumb: true
    Page: 
     Label: 10
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 360, 593, 369, 601
      Annotation: 
       Subtype: Link
       Rect: 371, 591, 514, 599
     Thumb: true
    Page: 
     Label: 11
     Annotations: 
      Annotation: 
       Subtype: Link
       Rect: 62, 532, 115, 540
      Annotation: 
       Subtype: Link
       Rect: 120, 532, 219, 540
      Annotation: 
       Subtype: Link
       Rect: 425, 423, 524, 431
      Annotation: 
       Subtype: Link
       Rect: 320, 410, 343, 418
     Thumb: true
  Checksum: cf77016e
   Type: CRC32
  Checksum: ced1e44f5df4f4a4a4a6e711739f5e11
   Type: MD5
  Checksum: 19a3ed4d3969677279e3f0713fb54806533f9ec2
   Type: SHA-1